Rebus Biosystems develops an imaging system for analyzing genes in single cells using its patented Synthetic Aperture Optics system for multiple gene expression analysis. Its Rebus Esper platform integrates imaging, fluidics, chemistry, and bioinformatics to deliver spatial omics data. Founded in 2006 in Santa Clara, United States, the company has raised $20.0M in Series B funding from investors including Illumina Ventures and HHS. Developer of an imaging system for the analysis of genes in a single cell. The company’s patented technology includes a Synthetic Aperture Optics system used for the analysis of multiple gene expressions in single cells. This technology can be used for imaging full tissue sections using laser beams at subcellular resolution.
Rebus Biosystems
Series BRebus Biosystems develops an imaging system for analyzing genes in single cells using its patented Synthetic Aperture Optics system for multiple gene expression analysis. Its Rebus Esper platform integrates imaging, fluidics, chemistry, and bioinformatics to deliver spatial omics data. Founded in 2006 in Santa Clara, United States, the company has raised $20.0M in Series B funding from investors including Illumina…
About
Business model
Genomics > Enabling Technologies > Instrument Systems > Single Cell Genomics,
Life Sciences Platforms and Tools > Instruments > Cell Biology > Cell Analysis > Single Cell Multi Omics
Team background
College Wise > Massachusetts Institute of Technology, University of California (Berkeley)
Institutional investors
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Backed by funds in our directory
🗂️ Explore Life Sciences investors — funds that write checks in this sector.